Early Access — free while we kick the tires
EdgarHawk

MEHRA SANJEEV K

Director

Director
2 filings analyzed · 1 company · Latest 2026-03-11

Companies

Company Buys Sells Direction
Avantor, Inc. AVTR 3 0 Net buying

Activity

March 2026
2026-03-11 Avantor, Inc. AVTR
medium
Buy
125,000 shares
$1,001,250
Significance 4/10

Director Sanjeev K Mehra bought 125,000 AVTR shares at $8.01 on 2026-03-10 ($1.0M); stock down -52.6% from 52-week high, company unprofitable.

Director Mehra purchased 125,000 shares at $8.01, expanding his holdings by 35.7% to 475,000 shares. The purchase occurs with AVTR trading at $8.29—down -52.6% from its 52-week high of $17.50 and -26.2% over the prior 30 days—against a backdrop of fundamental weakness: the company generated revenue of $1,623,800,000.00 but reported a net loss of $-711,800,000.00 and has contracted -3.4% year-over-year. Mehra's own prior buy at this ticker on 2025-12-05 was ill-timed, with that purchase producing -23.2% by the 90-day mark, and his cross-ticker track record shows 0% wins at 90 days with an average -23.2% return. The timing context and repeated exposure to a deteriorating position merit scrutiny, though the transaction price relative to current market levels provides limited directional signal on its own.

December 2025
2025-12-09 Avantor, Inc. AVTR
high
Buy
350,000 shares
$3,881,500
Significance 6/10

Director Mehra buys 350.0K shares at $11.09 in AVTR as stock down -53.1% from 52-week high of $22.66

Director Sanjeev K Mehra purchased 350,000 shares at $11.09 for $3,881,500.00, establishing a new position after holding zero shares. The transaction occurs as Avantor trades at $10.63, down 53.1% from its 52-week high of $22.66 and down 15.7% over the past 90 days, suggesting significant price deterioration in the period preceding the purchase. The company reported a net loss of $711.8M in the latest quarter against revenue of $1.6B, while annual revenue growth stands at -2.6%, indicating operational challenges alongside the equity decline. This substantial purchase by a director into a depressed stock valuation warrants investor attention to understand the strategic rationale and confidence level behind this commitment.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access